William Harris Investors’s Novavax NVAX Stock Holding History

William Harris Investors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-33,396	Closed	-$4.86M	–	95
2016 Q2	$4.86M	Buy	33,396 +8,000	+32%	+$917K	1.22%	32
2016 Q1	$2.62M	Buy	25,396 +1,130	+5%	+$121K	0.66%	39
2015 Q4	$4.07M	Sell	24,266 -167	-0.7%	-$25.7K	0.98%	34
2015 Q3	$3.46M	Buy	24,433 +4,917	+25%	+$1.1M	0.98%	37
2015 Q2	$4.35M	Sell	19,516 -18,919	-49%	-$3.33M	1.21%	34
2015 Q1	$6.36M	Sell	38,435 -11,336	-23%	-$1.84M	1.67%	27
2014 Q4	$5.9M	Sell	49,771 -5,648	-10%	-$590K	1.52%	30
2014 Q3	$4.62M	Buy	55,419 +6,019	+12%	+$544K	1.38%	29
2014 Q2	$4.57M	Buy	49,400 +13,400	+37%	+$1.18M	1.27%	32
2014 Q1	$3.26M	Buy	+36,000	New	+$4.02M	0.94%	36
2013 Q4	–	Sell	-52,000	Closed	-$3.28M	–	93
2013 Q3	$3.28M	Buy	+52,000	New	+$2.93M	1.02%	35

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Harris Investors's NVAX Position: Q3 2016 in Review

William Harris Investors sold out of Novavax (NVAX) in Q3 2016, closing a stake of 33,396 shares — an estimated $4.86M sold.

William Harris Investors first reported a position in NVAX in Q3 2013 and held it in 11 quarters. The position peaked at $6.36M in Q1 2015. 167 funds tracked by Wall St. Rank hold NVAX as of Q3 2016.

William Harris Investors reported no remaining Novavax position as of Q3 2016 after selling out during the quarter.
William Harris Investors sold 33,396 Novavax shares in Q3 2016, an estimated $4.86M.
William Harris Investors first reported a position in Novavax in Q3 2013 and held it in 11 quarters.
William Harris Investors's Novavax position peaked at $6.36M in Q1 2015.
167 funds tracked by Wall St. Rank held Novavax as of Q3 2016.

Based on William Harris Investors's 13F filing for Q3 2016, filed 9 Nov 2016.